releasing agent

A releasing agent is a drug that causes a neuron to actively expel stored neurotransmitter into the synapse, rather than simply prolonging a signal that is already there. The distinction matters: reuptake inhibitors block the removal of neurotransmitter after it has been released naturally; releasing agents skip that step and force release directly.

Because the effect is active rather than passive, releasing agents can produce a much larger and faster surge of neurotransmitter than ordinary neuronal firing would generate.

How it works · its role

Monoamine neurons store neurotransmitter in small membrane-bound pouches called vesicles. A releasing agent typically enters the neuron by hitching a ride on the same protein transporter that normally recycles neurotransmitter — the DAT (DAT), NET (NET), or SERT (SERT).

Once inside, the drug disrupts the vesicles, flooding the interior of the neuron with neurotransmitter. It then runs the transporter in reverse, pumping that neurotransmitter out into the synapse rather than in. The result is a wave of signalling that the neuron did not initiate on its own.

Relevance to substances & effects

Amphetamines are the most studied class of releasing agents, acting primarily on dopamine and norepinephrine. The dopamine surge they produce is responsible for the stimulant, euphoric, and appetite-suppressing effects the class is known for; the norepinephrine release raises heart rate and blood pressure and sharpens alertness.

MDMA is a releasing agent across all three monoamine systems — dopamine, norepinephrine, and especially serotonin — and its strong serotonin release is thought to underlie the empathogenic and prosocial character of the experience, setting it apart from amphetamines.

Because releasing agents deplete the stored pool of neurotransmitter, the surge is followed by a period of relative deficit. This is the likely basis of the low mood or fatigue that can follow a heavy dose — sometimes called a comedown — and it is one reason the effects of releasing agents are self-limiting in a way that receptor agonists are not.